source
- Cellular Intelligence hires neurologist to assess Novo Nordisk's Parkinson's stem cell programCellular Intelligence, an AI‑driven biotech, announced it is evaluating Novo Nordisk's Parkinson's stem cell therapy after Novo shut down its cell therapy unit. The company engaged neurologist and…
- Eli Lilly leads biotech M&A in H1, leveraging obesity drug success and trillion-dollar scaleEli Lilly, already the largest pharmaceutical company, has emerged as a leading buyer of biotech assets in the first half of 2026. Its trillion-dollar market size and recent successes in obesity t…